2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ... Arthritis & Rheumatism 65 (11), 2737-2747, 2013 | 5681 | 2013 |
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including … W Zhang, M Doherty, T Bardin, E Pascual, V Barskova, P Conaghan, ... Annals of the rheumatic diseases 65 (10), 1312-1324, 2006 | 2231 | 2006 |
Update of EULAR recommendations for the treatment of systemic sclerosis O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ... Annals of the rheumatic diseases 76 (8), 1327-1339, 2017 | 1241 | 2017 |
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial JM Van Laar, D Farge, JK Sont, K Naraghi, Z Marjanovic, J Larghero, ... Jama 311 (24), 2490-2498, 2014 | 819 | 2014 |
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases V Furer, C Rondaan, MW Heijstek, N Agmon-Levin, S Van Assen, M Bijl, ... Annals of the rheumatic diseases 79 (1), 39-52, 2020 | 815 | 2020 |
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative F Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, A Tyndall, ... Wiley Periodicals, Inc., 2013 | 753 | 2013 |
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial D Baeten, X Baraliakos, J Braun, J Sieper, P Emery, D Van der Heijde, ... The Lancet 382 (9906), 1705-1713, 2013 | 751 | 2013 |
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial D Khanna, CP Denton, A Jahreis, JM van Laar, TM Frech, ME Anderson, ... The lancet 387 (10038), 2630-2640, 2016 | 720 | 2016 |
Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 634 | 2017 |
Mortality in systemic sclerosis: an international meta-analysis of individual patient data JPA Ioannidis, PG Vlachoyiannopoulos, AB Haidich, TA Medsger Jr, ... The American journal of medicine 118 (1), 2-10, 2005 | 596 | 2005 |
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 581 | 2020 |
The clinical utility of bone marker measurements in osteoporosis G Wheater, M Elshahaly, SP Tuck, HK Datta, JM van Laar Journal of translational medicine 11, 1-14, 2013 | 520 | 2013 |
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ... Annals of the rheumatic diseases 74 (6), 1188-1194, 2015 | 500 | 2015 |
Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells ME Morgan, R Flierman, LM van Duivenvoorde, HJ Witteveen, ... Arthritis & Rheumatism 52 (7), 2212-2221, 2005 | 485 | 2005 |
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus TRDJ Radstake, O Gorlova, B Rueda, JE Martin, BZ Alizadeh, ... Nature genetics 42 (5), 426-429, 2010 | 480 | 2010 |
EULAR definition of difficult-to-treat rheumatoid arthritis G Nagy, NMT Roodenrijs, PMJ Welsing, M Kedves, A Hamar, ... Annals of the rheumatic diseases 80 (1), 31-35, 2021 | 466 | 2021 |
Building islands of expertise in everyday family activity K Crowley, M Jacobs Learning conversations in museums, 337-360, 2003 | 411 | 2003 |
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation JA Snowden, R Saccardi, M Allez, S Ardizzone, R Arnold, R Cervera, ... Bone marrow transplantation 47 (6), 770-790, 2012 | 365 | 2012 |
Involvement of functional autoantibodies against vascular receptors in systemic sclerosis G Riemekasten, A Philippe, M Näther, T Slowinski, DN Müller, ... Annals of the rheumatic diseases 70 (3), 530-536, 2011 | 363 | 2011 |
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease M Binks, JR Passweg, D Furst, P McSweeney, K Sullivan, C Besenthal, ... Annals of the rheumatic diseases 60 (6), 577-584, 2001 | 353 | 2001 |